Artificial intelligence in virtual screening: Models versus experiments

NA Murugan, GR Priya, GN Sastry, S Markidis - Drug Discovery Today, 2022 - Elsevier
A typical drug discovery project involves identifying active compounds with significant
binding potential for selected disease-specific targets. Experimental high-throughput …

Antibiotic discovery in the artificial intelligence era

T Lluka, JM Stokes - Annals of the New York Academy of …, 2023 - Wiley Online Library
As the global burden of antibiotic resistance continues to grow, creative approaches to
antibiotic discovery are needed to accelerate the development of novel medicines. A rapidly …

Molecular sets (MOSES): a benchmarking platform for molecular generation models

D Polykovskiy, A Zhebrak… - Frontiers in …, 2020 - frontiersin.org
Generative models are becoming a tool of choice for exploring the molecular space. These
models learn on a large training dataset and produce novel molecular structures with similar …

Predicting or pretending: artificial intelligence for protein-ligand interactions lack of sufficiently large and unbiased datasets

J Yang, C Shen, N Huang - Frontiers in pharmacology, 2020 - frontiersin.org
Predicting protein-ligand interactions using artificial intelligence (AI) models has attracted
great interest in recent years. However, data-driven AI models unequivocally suffer from a …

A quick guide to small-molecule inhibitors of eukaryotic protein synthesis

SE Dmitriev, DO Vladimirov, KA Lashkevich - Biochemistry (Moscow), 2020 - Springer
Eukaryotic ribosome and cap-dependent translation are attractive targets in the antitumor,
antiviral, anti-inflammatory, and antiparasitic therapies. Currently, a broad array of small …

Machine learning in antibacterial drug design

M Jukič, U Bren - Frontiers in Pharmacology, 2022 - frontiersin.org
Advances in computer hardware and the availability of high-performance supercomputing
platforms and parallel computing, along with artificial intelligence methods are successfully …

Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry

SA Kumar, TD Ananda Kumar… - Future Medicinal …, 2022 - Taylor & Francis
Predicting novel small molecule bioactivities for the target deconvolution, hit-to-lead
optimization in drug discovery research, requires molecular representation. Previous reports …

Machine learning in antibacterial discovery and development: A bibliometric and network analysis of research hotspots and trends

K Diéguez-Santana, H González-Díaz - Computers in Biology and Medicine, 2023 - Elsevier
Abstract Machine learning (ML) methods are used in cheminformatics processes to predict
the activity of an unknown drug and thus discover new potential antibacterial drugs. This …

Recent advances in drug repurposing using machine learning

F Urbina, AC Puhl, S Ekins - Current opinion in chemical biology, 2021 - Elsevier
Drug repurposing aims to find new uses for already existing and approved drugs. We now
provide a brief overview of recent developments in drug repurposing using machine …

The application of machine learning techniques to innovative antibacterial discovery and development

MSM Serafim, T Kronenberger, PR Oliveira… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction After the initial wave of antibiotic discovery, few novel classes of antibiotics have
emerged, with the latest dating back to the 1980's. Furthermore, the pace of antibiotic drug …